Discontinuing development of istisociclib, a CDK9 inhibitor; benefit-risk profile in platinum-resistant high-grade serous ovarian cancer does ...

UA researcher Leslie Farland, ScD in collaboration with Dalia Stern Solodkin, Ph.D. from Mexico’s Instituto Nacional de Salud ...

Analyst Andres Y. Maldonado of H.C. Wainwright reiterated a Buy rating on Mural Oncology Plc (MURA – Research Report), retaining the ...

Good morning, ladies and gentlemen and welcome to Aspira Women's Health Incorporated Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following ...

Former winner of TV show Alone Australia Gina Chick was diagnosed with breast cancer just days after finding out she was pregnant. She describes in ...

R&D Expenses: Research and development expenses for the third quarter of 2024 were $1.0 million, compared to $1.9 million for ...

Dr. Sandra Milligan, President of Aspira said, "Our in-development molecular tests for ovarian cancer and endometriosis ... including those factors identified as "risk factors” in our most recent ...

On Wednesday, Murray joined Denise Pines and Tamsen Fadal, national advocates for improving menopause care and executive ...

Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC <a target=_blank href=http ...

Pregnancy complicates a cancer diagnosis in many ways. So cancer treatment may need to be adjusted. Here’s what we know so ...

ATA 2024 spotlighted new research to help endocrinologists manage the subsequent fertility, bone health, and cardiovascular ...

Posters will be presented at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC), being held November ... and other risks and uncertainties that are described in the Risk Factors ...